Skip to main content

Advertisement

SpringerLink
Log in

Potential effects of bisphosphonates on bone ultrastructure

  • Bone Quality Seminars: Ultrastructure
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates JA, Meunier PJ (1997) Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475–1480

    Article  PubMed  CAS  Google Scholar 

  2. Recker RR, Weinstein RS, Chesnut CHIII, Schimmer RC, Mahoney P, Hughes C et al (2004) Histomorphometric evaluation of daily and intermittent oral ibandronate in women with post menopausal osteoporosis: results from the BONE study. Osteoporos Int 15:231–237

    Article  PubMed  CAS  Google Scholar 

  3. Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA et al (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23:6–16

    Article  PubMed  CAS  Google Scholar 

  4. Boivin GY, Chavassieux PM, Santora AC, Yates JA, Meunier PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralisation of bone tissue in osteoporotic women. Bone 27:687–694

    Article  PubMed  CAS  Google Scholar 

  5. Roschger P, Rinnerthaler S, Yates JA, Rodan GA, Fratzl P, Klaushoffer K (2001) Alendronate increases degree and uniformity of mineralisation in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185–191

    Article  PubMed  CAS  Google Scholar 

  6. Borah B, Dufresne TE, Ritman EL, Jorgensen SM, Liu S, Chmielewski PA et al (2006) Long-term risedronate treatment normalizes mineralisation and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. Bone 39:345–352

    Article  PubMed  CAS  Google Scholar 

  7. Borah B, Ritman EL, Dufresne TE, Jorgensen SM, Liu S, Sacha J et al (2005) The effect of risedronate on bone mineralisation as measured by micro-computed tomography with synchroton radiation: correlation to histomorphometric indices of turnover. Bone 37:1–9

    Article  PubMed  CAS  Google Scholar 

  8. Zoehrer R, Roschgber P, Paschalis EP, Hofstaetter JG, Durchschlag E, Fratzl P et al (2006) Effects of 3- and 5-year treatment with risedronate on bone mineralisation density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 21:1106–1112

    Article  PubMed  CAS  Google Scholar 

  9. Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K (2007) Evidence that treatment with risedronate in women with post menopausal osteoporosis affects bone mineralisation and bone volume. Calcif Tissue Int 81:73–80

    Article  PubMed  CAS  Google Scholar 

  10. Durchschlag E, Paschalis EP, Zoehrer R, Roschger P, Fratzl P, Recker R et al (2006) Bone material properties in trabecular bone form human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res 21:1581–1590

    Article  PubMed  CAS  Google Scholar 

  11. Russell RGG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733–759

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Rheumatology Department, Cochin Hospital, Paris-Descartes University, Paris, France

    C. Roux

Authors
  1. C. Roux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Roux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roux, C. Potential effects of bisphosphonates on bone ultrastructure. Osteoporos Int 20, 1093–1095 (2009). https://doi.org/10.1007/s00198-009-0865-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-0865-6

Keywords

Search

Navigation